{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:08:43Z","timestamp":1794535723774,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003197","name":"agenzia italiana del farmaco, ministero della salute","doi-asserted-by":"publisher","award":["FARM6JS3R5"],"award-info":[{"award-number":["FARM6JS3R5"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"ministero della salute","doi-asserted-by":"publisher","award":["RF-2011-02348358"],"award-info":[{"award-number":["RF-2011-02348358"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016387","name":"grifols","doi-asserted-by":"crossref","award":["ALBUS Grifols Award"],"award-info":[{"award-number":["ALBUS Grifols Award"]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100016387","name":"grifols","doi-asserted-by":"crossref","award":["2015"],"award-info":[{"award-number":["2015"]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann. Intensive Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of intravenous immunoglobulins (IVIG) during sepsis is controversial, as different trials on IVIG have observed inconsistent survival benefits. We aimed to elucidate the possible association and clinical significance between circulating levels of immunoglobulins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a subset of 956 patients with severe sepsis and septic shock of the multicentre, open-label RCT ALBIOS, venous blood samples were serially collected 1, 2, and 7\u00a0days after enrolment (or at ICU discharge, whichever came first). IgA, IgG and IgM concentrations were assayed in all patients on day 1 and in a subgroup of 150 patients on days 2 and 7. Ig concentrations were measured employing a turbidimetric assay, OSR61171 system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IgA on day 1 had a significant predictive value for both 28-day and 90-day mortality (28-day mortality, HR: 1.50 (95% CI 1.18\u20131.92); 90-day mortality, HR: 1.54 (95% CI 1.25\u20131.91)). IgG, but not IgM, on day 1 showed similar results for 28-day (HR 1.83 (95% CI 1.33\u20132.51) and 90-day mortality HR: 1.66 (95% CI 1.23\u20132.25)). In addition, lower levels of IgG but not of IgA and IgM, at day 1 were associated with significantly higher risk of secondary infections (533 [406\u2013772] vs 600 [452\u2013842] mg\/dL, median [Q1\u2013Q3],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the largest cohort study of patients with severe sepsis or septic shock, we found that high levels of IgA and IgG on the first day of diagnosis were associated with a decreased 90-day survival. No association was found between IgM levels and survival. As such, the assessment of endogenous immunoglobulins could be a useful tool to identify septic patients at high risk of mortality.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      #NCT00707122, Clinicaltrial.gov, registered 30 June 2008\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13613-021-00952-z","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T03:03:23Z","timestamp":1637895803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial"],"prefix":"10.1016","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct00707122","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Laura","family":"Alagna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M. T. A.","family":"Meessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Bellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Albiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Caironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Principale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Vivona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Grasselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2 M.","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vieri","family":"Parrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Keim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Marzo Capozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio S.","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cortegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-4650","authenticated-orcid":false,"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"952_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"952_CR2","doi-asserted-by":"publisher","first-page":"ofy313","DOI":"10.1093\/ofid\/ofy313","volume":"5","author":"Y Sakr","year":"2018","unstructured":"Sakr Y, Jaschinski U, Wittebole X, Szakmany T, Lipman J, \u00d1amendys-Silva SA, et al. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis. 2018;5:ofy313.","journal-title":"Open Forum Infect Dis"},{"key":"952_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304\u201377.","journal-title":"Intensive Care Med"},{"key":"952_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ccc.2017.08.007","volume":"34","author":"F Venet","year":"2018","unstructured":"Venet F, Rimmel\u00e9 T, Monneret G. Management of sepsis-induced immunosuppression. Crit Care Clin. 2018;34:97\u2013106.","journal-title":"Crit Care Clin"},{"key":"952_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840\u201351.","journal-title":"N Engl J Med"},{"key":"952_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/SHK.0b013e3181a2c0b2","volume":"32","author":"FS Taccone","year":"2009","unstructured":"Taccone FS, Stordeur P, De Backer D, Creteur J, Vincent J-L. \u03b3-Globulin levels in patients with community-acquired septic shock. Shock. 2009;32:379\u201385.","journal-title":"Shock"},{"key":"952_CR7","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00134-015-3845-7","volume":"41","author":"M Shankar-Hari","year":"2015","unstructured":"Shankar-Hari M, Culshaw N, Post B, Tamayo E, Andaluz-Ojeda D, Bermejo-Mart\u00edn JF, et al. Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis. Intensive Care Med. 2015;41:1393\u2013401.","journal-title":"Intensive Care Med"},{"key":"952_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmi.2016.01.021","volume":"22","author":"EJ Giamarellos-Bourboulis","year":"2016","unstructured":"Giamarellos-Bourboulis EJ, Tziolos N, Routsi C, Katsenos C, Tsangaris I, Pneumatikos I, et al. Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins. Clin Microbiol Infect. 2016;22:499\u2013506.","journal-title":"Clin Microbiol Infect"},{"key":"952_CR9","doi-asserted-by":"publisher","first-page":"616511","DOI":"10.3389\/fmed.2021.616511","volume":"8","author":"S Busani","year":"2021","unstructured":"Busani S, Roat E, Tosi M, Biagioni E, Coloretti I, Meschiari M, et al. Adjunctive immunotherapy with polyclonal Ig-M enriched immunoglobulins for septic shock: from bench to bedside the rationale for a personalized treatment protocol. Front Med. 2021;8:616511.","journal-title":"Front Med"},{"issue":"Suppl 1","key":"952_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cei.1996.104.s1.3","volume":"104","author":"L Mouthon","year":"1996","unstructured":"Mouthon L, Kaveri SV, Spalter SH, Lacroix-Desmazes S, Lefranc C, Desai R, et al. Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol. 1996;104(Suppl 1):3\u20139.","journal-title":"Clin Exp Immunol"},{"key":"952_CR11","first-page":"2686","volume":"35","author":"KB Laupland","year":"2007","unstructured":"Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med. 2007;35:2686\u201392.","journal-title":"Crit Care Med"},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/CCM.0000000000002627","volume":"45","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Singer M, Spencer J. Can concurrent abnormalities in free light chains and immunoglobulin concentrations identify a target population for immunoglobulin trials in sepsis? Crit Care Med. 2017;45:1829\u201336.","journal-title":"Crit Care Med"},{"key":"952_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13613-017-0268-3","volume":"7","author":"I Martin-Loeches","year":"2017","unstructured":"Martin-Loeches I, Muriel-Bomb\u00edn A, Ferrer R, Artigas A, Sole-Violan J, Lorente L, et al. The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure. Ann Intensive Care. 2017;7:44.","journal-title":"Ann Intensive Care"},{"key":"952_CR14","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1305727.","journal-title":"N Engl J Med"},{"key":"952_CR15","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101:1644\u201355.","journal-title":"Chest"},{"key":"952_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707\u201310.","journal-title":"Intensive Care Med"},{"key":"952_CR17","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/cc13183","volume":"18","author":"S Masson","year":"2014","unstructured":"Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian outcome sepsis trial. Crit Care. 2014;18:R6.","journal-title":"Crit Care"},{"key":"952_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/eci.12704","volume":"47","author":"P Caironi","year":"2017","unstructured":"Caironi P, Masson S, Mauri T, Bottazzi B, Leone R, Magnoli M, et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. Eur J Clin Invest. 2017;47:73\u201383.","journal-title":"Eur J Clin Invest"},{"key":"952_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/joim.13150","volume":"289","author":"A Vecchi\u00e9","year":"2021","unstructured":"Vecchi\u00e9 A, Bonaventura A, Meessen J, Novelli D, Minetti S, Elia E, et al. PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study. J Intern Med. 2021;289:179\u201392.","journal-title":"J Intern Med"},{"key":"952_CR20","doi-asserted-by":"crossref","first-page":"e13333","DOI":"10.1111\/eci.13333","volume":"50","author":"A Bonaventura","year":"2020","unstructured":"Bonaventura A, Carbone F, Vecchi\u00e9 A, Meessen J, Ferraris S, Beck E, et al. The role of resistin and myeloperoxidase in severe sepsis and septic shock: results from the ALBIOS trial. Eur J Clin Investig. 2020;50:e13333.","journal-title":"Eur J Clin Investig"},{"key":"952_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejim.2020.04.035","volume":"78","author":"F Carbone","year":"2020","unstructured":"Carbone F, Bonaventura A, Vecchi\u00e8 A, Meessen J, Minetti S, Elia E, et al. Early osteopontin levels predict mortality in patients with septic shock. Eur J Intern Med. 2020;78:113\u201320.","journal-title":"Eur J Intern Med"},{"key":"952_CR22","doi-asserted-by":"publisher","first-page":"A264","DOI":"10.1097\/01.ccm.0000440286.31999.57","volume":"41","author":"FS Taccone","year":"2013","unstructured":"Taccone FS, Caironi P, Taccone W, Latini R, Masson S, Tognoni G, et al. 1050: Gamma-globulin levels in patients with septic shock. Crit Care Med. 2013;41:A264.","journal-title":"Crit Care Med"},{"key":"952_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","volume":"151","author":"A Gonzalez-Quintela","year":"2008","unstructured":"Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008;151:42\u201350.","journal-title":"Clin Exp Immunol"},{"key":"952_CR24","first-page":"517","volume":"34","author":"F Dati","year":"1996","unstructured":"Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC\/BCR\/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologist. Eur J Clin Chem Clin Biochem. 1996;34:517\u201320.","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"952_CR25","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1515\/cclm-2014-1186","volume":"53","author":"B Puissant-Lubrano","year":"2015","unstructured":"Puissant-Lubrano B, Peres M, Apoil P-A, Congy-Jolivet N, Roubinet F, Blancher A. Immunoglobulin IgA, IgD, IgG, IgM and IgG subclass reference values in adults. Clin Chem Lab Med. 2015;53:e359.","journal-title":"Clin Chem Lab Med"},{"key":"952_CR26","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1097\/CCM.0000000000003050","volume":"46","author":"H R\u00f8sj\u00f8","year":"2018","unstructured":"R\u00f8sj\u00f8 H, Masson S, Caironi P, Stridsberg M, Magnoli M, Christensen G, et al. Prognostic value of secretoneurin in patients with severe sepsis and septic shock: data from the albumin Italian outcome sepsis study. Crit Care Med. 2018;46:e404\u201310.","journal-title":"Crit Care Med"},{"key":"952_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/joim.12265","volume":"276","author":"JF Bermejo-Mart\u00edn","year":"2014","unstructured":"Bermejo-Mart\u00edn JF, Rodriguez-Fernandez A, Herr\u00e1n-Monge R, Andaluz-Ojeda D, Muriel-Bomb\u00edn A, Merino P, et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med. 2014;276:404\u201312.","journal-title":"J Intern Med"},{"key":"952_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13054-015-0793-0","volume":"19","author":"R Almansa","year":"2015","unstructured":"Almansa R, Tamayo E, Andaluz-Ojeda D, Nogales L, Blanco J, Eiros JM, et al. The original sins of clinical trials with intravenous immunoglobulins in sepsis. Crit Care. 2015;19:90.","journal-title":"Crit Care"},{"key":"952_CR29","doi-asserted-by":"publisher","first-page":"R243","DOI":"10.1186\/cc10501","volume":"15","author":"D Andaluz-Ojeda","year":"2011","unstructured":"Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gand\u00eda F, et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care. 2011;15:R243.","journal-title":"Crit Care"},{"key":"952_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00063-016-0220-6","volume":"112","author":"S Dietz","year":"2017","unstructured":"Dietz S, Lautenschl\u00e4ger C, M\u00fcller-Werdan U, Pilz G, Fraunberger P, P\u00e4sler M, et al. Serum IgG levels and mortality in patients with severe sepsis and septic shock. Med Klin Intensivmed Notfmed. 2017;112:462\u201370.","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"952_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1086\/317423","volume":"31","author":"A Norrby-Teglund","year":"2000","unstructured":"Norrby-Teglund A, Ihendyane N, Kansal R, Basma H, Kotb M, Andersson J, et al. Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens. Clin Infect Dis. 2000;31:1175\u201382.","journal-title":"Clin Infect Dis"},{"key":"952_CR32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00075198-200110000-00007","volume":"7","author":"K Werdan","year":"2001","unstructured":"Werdan K. Intravenous immunoglobulin for prophylaxis and therapy of sepsis. Curr Opin Crit Care. 2001;7:354\u201361.","journal-title":"Curr Opin Crit Care"},{"key":"952_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/cc10597","volume":"16","author":"M Shankar-Hari","year":"2012","unstructured":"Shankar-Hari M, Spencer J, Sewell WA, Rowan KM, Singer M. Bench-to-bedside review: Immunoglobulin therapy for sepsis\u2014biological plausibility from a critical care perspective. Crit Care. 2012;16:206.","journal-title":"Crit Care"},{"key":"952_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nrmicro1824","volume":"6","author":"JD Lambris","year":"2008","unstructured":"Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol. 2008;6:132\u201342.","journal-title":"Nat Rev Microbiol"},{"key":"952_CR35","doi-asserted-by":"publisher","first-page":"R247","DOI":"10.1186\/cc13073","volume":"17","author":"EJ Giamarellos-Bourboulis","year":"2013","unstructured":"Giamarellos-Bourboulis EJ, Apostolidou E, Lada M, Perdios I, Gatselis NK, Tsangaris I, et al. Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit Care. 2013;17:R247.","journal-title":"Crit Care"},{"key":"952_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1126\/science.1215173","volume":"335","author":"PJ Rauch","year":"2012","unstructured":"Rauch PJ, Chudnovskiy A, Robbins CS, Weber GF, Etzrodt M, Hilgendorf I, et al. Innate response activator B cells protect against microbial sepsis. Science. 2012;335:597\u2013601.","journal-title":"Science"},{"key":"952_CR37","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.intimp.2011.08.024","volume":"11","author":"F Venet","year":"2011","unstructured":"Venet F, Gebeile R, Bancel J, Guignant C, Poitevin-Later F, Malcus C, et al. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol. 2011;11:2086\u201390.","journal-title":"Int Immunopharmacol"},{"key":"952_CR38","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang C-CH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:2003\u201317.","journal-title":"JAMA"},{"key":"952_CR39","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, Wiewel MA, Davenport EE, Burnham KL, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. 2017;5:816\u201326.","journal-title":"Lancet Respir Med"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-021-00952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-021-00952-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-021-00952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:39:05Z","timestamp":1767767945000},"score":1,"resource":{"primary":{"URL":"https:\/\/annalsofintensivecare.springeropen.com\/articles\/10.1186\/s13613-021-00952-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1186\/s13613-021-00952-z","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and the informed consent process were approved by the ethics committee at each participating institution. Written informed consent or deferred consent was obtained from each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}